Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The idea is to initially place the device in medical waiting areas, from where it would help prepare staff for caseload ebbs and flows. Later it might be set in larger public spaces, helping to monitor epidemiological trends at the population level.
Pharmaceutical giant Eli Lilly has partnered with AbCellera Biologics, a biotechnology company based in Canada, to address the new coronavirus crisis by developing antibody products to treat and prevent the virus.
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health have begun a Phase 1 clinical trial for a vaccine to protect against the new coronavirus, COVID-19.
One algorithmic approach used to model and analyze complex networks is fundamentally flawed and fails to capture the full properties of real-world complexities, according to a new study published in Proceedings of the National Academy of Sciences.
